Ongoing Studies

The Alzheimer's Disease Neuroimaging Initiative

A new Alzheimer disease study is now underway at the University of Wisconsin Comprehensive Memory Program. This study is for persons diagnosed with Mild Alzheimer Disease and Mild Cognitive Impairment. Cognitively healthy control subjects are also being recruited.

The goal of this study is to determine whether MRI or PET imaging of the brain every six months can help predict the onset and monitor the progression of Alzheimer’s disease. For study brochures and eligibility criteria visit the Alzheimer Disease Education and Referral Center. This study is sponsored by the NIH and is being conducted at 50 sites across the USA.

If you are interested in this study, contact Gemma by email or phone (608) 256-1901 x 11075.

Early Detection of Alzheimer Disease with Functional Neuroimaging

The purpose of this NIH sponsored study is to investigate the organization of memory and develop future methods for early detection of AD.  Using functional magnetic resonance imaging (fMRI), we examine the responsiveness of the brain to memory tasks, specifically focusing on regions of the brain that are known to be involved in early stages of Alzheimer’s disease (AD), even before the onset of observable symptoms. 

The study visit takes approximately 3-4 hours and includes an MRI, memory and thinking tests, and a blood draw.  We are currently enrolling healthy adults ages 40-65 without a family history of Alzheimer’s disease, as well as participants in the Wisconsin Registry for Alzheimer’s Prevention.  Also, we are continually enrolling persons with a diagnosis of Mild Cognitive Impairment.  Please contact Britta Torgerson at (608) 256-1901 x 11418 for more information.